HEART FAILURE OF REDUCED EJECTION FRACTION (HFREF)

Clinical trials for HEART FAILURE OF REDUCED EJECTION FRACTION (HFREF) explained in plain language.

Never miss a new study

Get alerted when new HEART FAILURE OF REDUCED EJECTION FRACTION (HFREF) trials appear

Sign up with your email to follow new studies for HEART FAILURE OF REDUCED EJECTION FRACTION (HFREF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Massive 5,000-Person heart drug study launches in china

Disease control Not yet recruiting

This study aims to see how well the drug Jardiance works compared to other standard heart failure medications in real-world Chinese patients. It will follow 5,000 adults with a weakened heart to see which treatment is better at preventing hospital stays for heart failure or death…

Matched conditions: HEART FAILURE OF REDUCED EJECTION FRACTION (HFREF)

Sponsor: Boehringer Ingelheim • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

HEART FAILURE OF REDUCED EJECTION FRACTION (HFREF)

Get alerted when new HEART FAILURE OF REDUCED EJECTION FRACTION (HFREF) trials appear

Massive 5,000-Person heart drug study launches in china